Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $1.76M | $1.02M | +72.09% |
Operating Income | $-377.75M | $-291.85M | -29.43% |
Net Income | $-208.55M | $-126.41M | -64.98% |
EPS (Basic) | $-3.98 | $-2.92 | -36.30% |
EPS (Diluted) | $-3.98 | $-2.92 | -36.30% |
R&D Expense | $142.38M | $156.34M | -8.93% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $2.03B | $2.34B | -13.25% |
Current Assets | $1.73B | $2.01B | -13.77% |
Total Liabilities | $318.59M | $358.9M | -11.23% |
Current Liabilities | $104.36M | $127.82M | -18.35% |
Stockholders' Equity | $1.71B | $1.98B | -13.62% |
Cash & Equivalents | $193.62M | $484.47M | -60.04% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-167.83M | $14.17M | -1284.38% |
Investing Cash Flow | $50.22M | $-224.71M | +122.35% |
Financing Cash Flow | $12.85M | $305.47M | -95.79% |
D&A | $9.38M | $9.68M | -3.03% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -21499.6% | -28584.5% | +7084.92% |
Net Margin | -11869.6% | — | — |
ROE | -12.2% | — | — |
ROA | -10.3% | — | — |
Current Ratio | $16.612 | — | — |
Debt to Equity | $0.186 | — | — |
Other companies in Biotechnology